SIIT Screened World Equity Ex-US Fund OCSE:NOVO B Holdings History
SIIT Screened World Equity Ex-US Fund's Novo Nordisk AS Holding Summary
As of 2025-02-28, SEI INSTITUTIONAL INVESTMENTS TRUST held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and SEI INSTITUTIONAL INVESTMENTS TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then SIIT Screened World Equity Ex-US Fund has made 7 purchases of OCSE:NOVO B, at an average price of kr230.80, for a total of 60,392.00 shares. In addition, there have been 11 sales at an average price of kr475.22 for 60,392.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, SIIT Screened World Equity Ex-US Fund's estimated gain on his OCSE:NOVO B holdings is kr14.76 Mil, reflecting a 105.90% gain to date.
SIIT Screened World Equity Ex-US Fund OCSE:NOVO B (kr451.30) Holding Chart
SIIT Screened World Equity Ex-US Fund OCSE:NOVO B (kr451.30) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
